Studier angående hjärta vid ME1. Peckerman A, LaManca JJ, Dahl KA, et al. Abnormal impedance cardiography predicts symptom severity in chronic fatigue syndrome. Am J Med Sci 2003;326:55–60.
doi:10.1097/00000441-200308000-00001 [
PubMed]
2. LaManca JJ, Peckerman A, Walker J, et al. Cardiovascular response during head-up tilt in chronic fatigue syndrome. Clin Physiol 1999;19:111–20.
doi:10.1046/j.1365-2281.1999.00154.x [
PubMed]
3. Hollingsworth KG, Jones DE, Taylor R, et al. Impaired cardiovascular response to standing in chronic fatigue syndrome. Eur J Clin Invest 2010;40:608–15.
doi:10.1111/j.1365-2362.2010.02310.x [
PubMed]
4. Hollingsworth KG, Hodgson T, Macgowan GA, et al. Impaired cardiac function in chronic fatigue syndrome measured using magnetic resonance cardiac tagging. J Intern Med 2012;271:264–70.
doi:10.1111/j.1365-2796.2011.02429.x [
PMC free article] [
PubMed]
5. Hurwitz BE, Coryell VT, Parker M, et al. Chronic fatigue syndrome: illness severity, sedentary lifestyle, blood volume and evidence of diminished cardiac function. Clin Sci 2009;118:125–35.
doi:10.1042/CS20090055 [
PubMed]
6. Newton JL, Finkelmeyer A, Petrides G, et al. Blamire a reduced cardiac volumes in chronic fatigue syndrome associate with plasma volume but not length of disease: a cohort study. openhrt 2016:e000381. [
PMC free article] [
PubMed]
7. Farquhar WB, Hunt BE, Taylor JA, et al. Blood volume and its relation to peak O(2) consumption and physical activity in patients with chronic fatigue. Am J Physiol Heart Circ Physiol 2002;282:H66–71. [
PubMed]
8. Miwa K, Fujita M. Cardiac function fluctuates during exacerbation and remission in young adults with chronic fatigue syndrome and “small heart”. J Cardiol 2009;54:29–35.
doi:10.1016/j.jjcc.2009.02.008 [
PubMed]
9. Miwa K, Fujita M. Small heart syndrome in patients with chronic fatigue syndrome. Clin Cardiol 2008;31:328–33.
doi:10.1002/clc.20227 [
PubMed]
10. Martin Lerner et al. 2004.
Prevalence of abnormal cardiac wall motion in the cardiomyopathy associated with incomplete multiplication of Epstein-barr Virus and/or cytomegalovirus in patients with chronic fatigue syndrome.
http://iv.iiarjournals.org/content/18/4/41711. Martin Lerner et al 2007
Valacyclovir treatment in Epstein-Barr virus subset chronic fatigue syndrome: thirty-six months follow-up.
http://iv.iiarjournals.org/content/21/5/707